Hajime Sakai
Gründer bei Napigen, Inc.
Vermögen: 688 123 $ am 31.05.2024
Profil
Hajime Sakai has founded Napigen, Inc. in 2016 and currently holds the titles of President, Chief Executive Officer & Director.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SHINTO PAINT CO., LTD.
1,07% | 30.09.2023 | 332 000 ( 1,07% ) | 266 201 $ | 31.05.2024 |
TOWNNEWS-SHA CO., LTD.
0,89% | 30.06.2023 | 49 500 ( 0,89% ) | 242 547 $ | 31.05.2024 |
| 31.12.2023 | 243 000 ( 1,30% ) | 179 375 $ | 31.05.2024 |
Aktive Positionen von Hajime Sakai
| Unternehmen | Position | Beginn |
|---|---|---|
Napigen, Inc.
 Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Gründer | 01.01.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
